title: Cytokine effects on cell survival and death of A549 lung carcinoma cells.
abstract: OBJECTIVE
  IL-13, TNF-α and IL-1β have various effects on lung cancer growth and death, but the signaling pathways mediating these effects have not been extensively analyzed. Therefore, the effects of IL-13, TNF-α and IL-1β alone, and in combination with Fas, on cell viability and death as well as major signaling pathways involved in these effects were investigated in A549 lung carcinoma cells.
  
  
  RESULTS
  Using MTT and flow cytometry, IL-13, TNF-α and IL-1β pretreatment decreased Fas-induced cell death. These anti-cell death effects were attenuated by pretreatment with inhibitors of Nuclear factor-κB [NF-κB], Phoshatidylinositole-3 kinase [PI3-K], JNK, p38 and ERK1/2 pathways. Using Western blot, IL-13, TNF-α and IL-1β treated cells showed time-dependent expression of p-ERK1/2, p-p38, p-JNK, p-Akt and p-IκBα proteins, decreased IκBα protein expression, no cleavage of Caspase-3 and PARP1 proteins and no notable alterations of Fas protein. IL-13 and TNF-α treated cells showed time-dependent increase of FLIPL expression.
  
  
  CONCLUSIONS
  IL-13, TNF-α and IL-1β attenuate the pro-cell death effects of Fas on A549 cells, at least partially, by pathways involving the NF-κB, PI3-K and MAP kinases, but not by alterations of Fas protein expression. The IL-13 and TNF-α cell survival effects may also be due to increased expression of FLIPL protein.
authors: Department of Anatomy-Histology-Embryology, Faculty of Medicine, University of Ioannina, Greece.
authors: Michalis
authors: M
authors: Kastamoulas
authors: Georgios
authors: G
authors: Chondrogiannis
authors: Panagiotis
authors: P
authors: Kanavaros
authors: Georgios
authors: G
authors: Vartholomatos
authors: Maria
authors: M
authors: Bai
authors: Evangelos
authors: E
authors: Briasoulis
authors: Dimitrios
authors: D
authors: Arvanitis
authors: Vasiliki
authors: V
authors: Galani
mesh_terms: D015153:Blotting, Western; D016923:Cell Death / Q000187:drug effects; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D016207:Cytokines / Q000494:pharmacology*; D005434:Flow Cytometry; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D015398:Signal Transduction / Q000187:drug effects; D013997:Time Factors
chemical_list: D016207:Cytokines